Atara Biotherapeutics (ATRA) Analyst & Key Data

Analyst Consensus

Hold3 analysts

Hold

Updated Sep 12, 2026

Total Analysts3

Buy

4

Hold

7

Sell

2

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$9.38

Median Target+56.40%

$14.67

Potential upside vs current price

Current Stock Price

$9.38

Median Target+56.40%

$14.67

Potential upside vs current price

Analyst Consensus

Hold3 analysts

Hold

Updated Sep 12, 2026

Total Analysts3

Buy

4

Hold

7

Sell

2

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$9.38

Median Target+56.40%

$14.67

Potential upside vs current price

Current Stock Price

$9.38

Median Target+56.40%

$14.67

Potential upside vs current price

Atara Biotherapeutics, Inc.